Shanghai Rendu Biotechnology Stock Filter Stocks by Fundamentals
| 688193 Stock | 42.92 0.08 0.19% |
Shanghai Rendu Biotechnology fundamentals help investors to digest information that contributes to Shanghai Rendu's financial success or failures. It also enables traders to predict the movement of Shanghai Stock. The fundamental analysis module provides a way to measure Shanghai Rendu's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai Rendu stock.
Shanghai |
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Shanghai Fundamentals
| Return On Equity | 0.0227 | |||
| Return On Asset | -0.0062 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 40 M | |||
| Shares Owned By Insiders | 60.13 % | |||
| Shares Owned By Institutions | 5.87 % | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 9.65 X | |||
| Revenue | 164.41 M | |||
| Gross Profit | 304.22 M | |||
| EBITDA | 2.87 M | |||
| Net Income | 8.26 M | |||
| Total Debt | 2.93 M | |||
| Book Value Per Share | 23.95 X | |||
| Cash Flow From Operations | 17.19 M | |||
| Earnings Per Share | 0.54 X | |||
| Number Of Employees | 358 | |||
| Beta | 0.23 | |||
| Market Capitalization | 1.72 B | |||
| Total Asset | 1.05 B | |||
| Retained Earnings | 136.46 M | |||
| Working Capital | 820.69 M | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.05 B | |||
| Last Dividend Paid | 0.3 |
About Shanghai Rendu Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai Rendu Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Rendu using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Rendu Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Rendu financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rendu security.